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Abstract. For the study of retinoprotective properties of pharmacological agents a model of retinal 
angiopathy of hypertensive type was created against the background of N-nitro-L-arginine methyl 
ester (L-NAME) administration in a dose 12.5 mg/kg rat body weight for 28 days. We studied the 
retinoprotective effects of minoxidil in a dose 0.5 mg/kg, sildenafil in a dose 0.5 mg/kg and distant 
ischemic preconditioning (DIP) on a model of retinal angiopathy of hypertensive type in Wistar rats. 
The experiment showed that minoxidil in a dose 0.5 mg/kg prevented the development of ischemic 
damage and retinal vascular changes of hypertensive type caused by the introduction of L-NAME for 
28 days, to a greater extent than sildenafil and distant ischemic preconditioning. The observed 
retinoprotective effects are confirmed by ophthalmoscopy, laser Doppler flowmetry (LDF) and 
electroretinography (ERG). The lack of positive dynamics in experimental groups with the 
introduction of glibenclamide in a dose 5 mg/kg confirms the key role of ATP-dependent potassium 
channels in the mechanism of realization of preconditioning. Detection of preconditioning properties 
of pharmacological agents may be a new approach in the correction and prevention of retinal 
angiopathy, which is the initial part of hypertensive retinopathy. 
Keywords: retinal angiopathy of hypertensive type, pharmacological preconditioning, minoxidil, 
sildenafil, hypertensive retinopathy. 
 
Introduction.  
Hypertension, existing for a long time, leads to 
serious complications in the so-called target organs 
(kidney, heart, brain, retina). Changes in the eye of high 
blood pressure among other manifestations of this 
pathology have a special place. The picture of the 
fundus and indicators of local hemodynamics 
significantly complement the representation of 
researchers about the features of the disease, can detect 
early signs of organic changes in the retinal vessels and 
judge by their state with a certain degree of confidence 
about the changes of regional vascular bed and on the 
vascular system of the body as a whole [1]. 
63% of hypertensive patients have evidence of 
hypertensive angiopathy [2]. To assess the changes in 
the fundus caused by hypertension, used classification 
of Krasnov ML, according to which there are three 
steps: stage I – hypertonic angiopathy; stage II – a 
hypertonic angiosclerosis; stage III – hypertensive 
angioretinopathy and neuroretinopathy. Hypertensive 
angiopathy is characterized by the first phase of 
hypertension, in which there are only functional 
vascular disorders and the pressure is unstable. 
Speaking about the pathogenesis of hypertensive 
retinopathy, it should be noted three main factors: the 
restriction and increased vascular permeability, and 
arteriosclerosis. Expressed arteriolar narrowing due 
to spasm of the walls takes place in response to 
increased blood pressure. The presence of bleeding 
on the surface of the retina caused by ruptures of the 
capillaries in the retinal nerve fiber layer in the 
posterior pole of the eye area [3]. 
The above changes in the retina, of course, lead 
to disruption of blood supply and the development of 
ischemic conditions, which can be corrected by 
pharmacological preconditioning. The phenomenon 
of ischemic preconditioning eventually realized by 
activation of the ATP-dependent potassium channels. 
As an end-effector of preconditioning, the ATP-
dependent potassium channels cause 
hyperpolarization of the cell membrane, as well as 
launching a system of nitrous oxide and a number of 
anti-apoptotic mechanisms [4, 5, 6, 7]. 
From our point of view, one of the most 
promising drugs with the effect of pharmacological 
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preconditioning and unstudied as retinoprotectors are 
minoxidil and sildenafil. 
The cardioprotective effect of minoxidil during 
heart preconditioning proved in experimental 
researches in vivo and in vitro [8]. The use of 
minoxidil (0,5 mg/kg/day) during simulated ischemia 
of the lower leg muscle helps to increase the level of 
the microcirculation to the 28
th
 day in 2,3 times in 
comparison with the control group, levels ischemic 
damage muscle tissue [9]. 
Recent studies have shown that inhibitors of 
phosphodiesterase - 5, in particular, sildenafil, have a 
stimulating effect on the nitric oxide pathway, 
exerting pronounced endothelioprotective effect, 
capable of activating protein kinase G and the ATP-
dependent potassium channels [10, 11].  
In connection with the above, it should be noted 
the relevance of study of retinoprotective effects of 
minoxidil, sildenafil on model of retinal angiopathy 
of hypertensive type. 
Objective: to increase the effectiveness of 
pharmacological correction of retinal angiopathy of 
hypertensive type using pharmacological 
preconditioning by minoxidil, sildenafil. 
Materials and methods.  
Experiments were carried out on Wistar rats 
weighing 225-275 g.  The rats were taken for the 
study with no external signs of disease, passed 
quarantine regime.  
Operations and other manipulations were 
performed on rats under general anesthesia by 
intraperitoneal (i/p) introducing an aqueous 
solution of chloral hydrate in a dose 300 mg/kg. 
L-NAME was injected in a dose 12.5 mg/kg/day 
for 28 days i/p daily. 
DIP was performed 10 min by the clamping the 
femoral artery to the proximal tourniquet third thigh 
for 40 min before the administration of L-NAME in 
odd days of the experiment. 
Minoxidil was administered intragastrically 
(i/g) in a dose 0.5 mg/kg 60 min before the 
administration of L-NAME in odd days of the 
experiment (every 48 hours). This dose of 
minoxidil is chosen by us, based on the literature 
data on pharmacological preconditioning by 
minoxidil [8, 9]. Drug administration explained by 
possible reduce of expressed hypotensive action due 
to the short half-life (4 hours) and longer period (48 
hours) of preconditioning action [12]. 
Sildenafil was administered i/p in a dose 0.5 
mg/kg 30 min before the administration of L-NAME 
in odd days of the experiment. This dose is chosen by 
us, based on the literature review of study of a 
possible correction of ischemic-reperfusion injury of 
various organs and tissues by sildenafil  [13, 14, 15]. 
Glibenclamide, a blocker of ATP-sensitive 
potassium channels, was administered i/g in a dose 
5 mg/kg [16] 90 min before the administration of 
L-NAME in odd days of the experiment. 
To measure blood pressure in rats (tail) a 
system of non-invasive measurement of blood 
pressure for small animals NIBP200 was used in 
the complex Biopac-systems MP-150. 
To investigate the fundus of experimental 
animals a direct ophthalmoscopy was used on 29 day 
of the experiment (ophthalmoscope Bx a Neitz, 
Japan). To expand the pupil the eye drops Irifrin 
2.5% were used. Ophthalmoscope has been 
approached to the rat eye and we sent in it a beam of 
light from a distance of 0.5-2 cm to obtain a clear 
picture of the fundus image. In the dim image of the 
fundus we picked up the lens by turning the disc of 
ophthalmoscope, which gives crisp image details of 
the fundus. To zoom a lens Osher MaxField 78D 
model OI-78M has been used. 
For subsequent statistical processing the degree 
of change, detected during ophthalmoscopy, were 
ranking (Tab. 1). 
Table 1. 
Methods of integrated semiquantitative evaluation of the fundus changes, detected during ophthalmoscopy (in grades). 
A set of attributes of fundus changes  Grades 
Optic disc is circular or oval shape and stands out from the fundus in pale - pink. The boundaries of the optic 
nerve disc are clear. It lies in the plane of the retina. From the middle of the optic nerve exit the central vessels 
of the retina. Blood vessels of the retina don`t have anastomoses. The veins and arteries are straightforward, 
caliber is uniform, not crimped. The general background is pink. 
0 
Angiopathy. Symptom Salus-Hun I. It is characterized by the presence of sclerosis of retinal vessels in fundus 
and "phenomenon of chiasm", which occurs due to indentation of artery at the site of chiasm with extended 
vein. Expansion of vein on both sides of the chiasm. Symptom Guist - expansion and corkscrew curl of 
venules located around the macular; observed in hypertensive disease. 
1 
Angiosclerosis. Symptom of copper wire - yellow glow of the retinal arteries; sign of hypertensive retinal 
angiopathy. Symptom Salus-Hun II - the formation of bulges in arteries and veins chiasm. 
Symptom Salus-Hun III - the disappearance of the vein at the site of crossing due to the formation of the 
arcuate bend, sinking deep into the retinal tissue. Symptom of silver wire. Increased vascular permeability. 
2 
 
 
3 
Retinopathy. "Cotton" exudates. Hemorrhages. In the macular area may be deposits of hard exudates in a star 
shape. 
4 
Hypertensive neuroretinopathy. Severe discoloration of the optic nerve. Swelling of the optic disc and 
peripapillary retina. Multiple foci of hemorrhage and "cotton" exudate, indicates the growing ischemia. 
5 
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Measuring of the microcirculation level in the 
rats retina was performed by LDF after examining 
the fundus. Registration is carried out by means of 
hardware and software Biopac-systems MP-150 and 
the needle-type sensor TSD-144 (USA) with 
AcqKnowledge 4.2 program. After animal anesthesia 
assessment of microcirculation level was carried out 
in ten points on the circumference of the eyeball, the 
recording duration of the microcirculation level 
readings at one point was 20 seconds. From the 
microcirculation level results at every point the 
average value has been calculated, which was taken 
as the indicator of the microcirculation level in the 
retina of the experimental animal. Value of 
microcirculation in the animal group was calculated 
as the average of the values obtained from each 
experimental animal in group [17]. 
ERG was performed immediately after the 
registration of the microcirculation level. For this 
the animals were kept in the dark for 30 minutes 
[18], further the animals were anesthetized 
(chloral hydrate, 300 mg/kg, i/p) and fixed on the 
table, isolated from the electromagnetic radiation. 
Corneal silver electrode was placed on the cornea 
that has been soaked by saline solution for better 
contact, the reference needle electrode EL452 has 
been placed subcutaneously in the region of the 
skull, ground needle electrode EL450 has been 
placed subcutaneously in the base of the tail. 
Strobe flash of white light that is connected to the 
stimulator STM200 by company Biopac System, 
Inc. (USA) has been placed behind the back of the 
animal, ERG registration was carried out in 
response to a single stimulation. Evoked 
biopotentials were run at a frequency of 1-1000 
Hz, amplified, averaged and presented graphically 
on the screen using the Biopac-systems MP-150 
with a computer program AcqKnowledge 4.2 
(USA). ERG-recording was carried out for 0.5 
seconds in each rat in groups. To assess the 
degree of functional damage to the retina we 
evaluated the ratio of amplitudes of a- and b- 
wave of ERG - the coefficient b/a [19]. From ten 
values in each group were taken the average, which 
was added to the protocol. 
For all data the descriptive statistics were used: 
data are checked for normal distribution. Distribution 
type was determined by using the criterion of 
Shapiro-Wilk. In case of normal distribution the 
average value (M) and standard error of the mean (m) 
were calculated. In cases of abnormal distribution the 
median (Me) and the quartile range (QR) were 
calculated. 
Between-group differences were analyzed by 
parametric (t-Student criterion) or non-parametric 
(Mann-Whitney test) methods, depending on the type 
of distribution. Differences were determined at 0.05 
significance level. Statistical analyzes were 
performed by using Statistica 10.0 software. 
The main part: 
The first step in study of the retinoprotective 
properties of pharmacological agents is the 
development of model of retinal angiopathy of 
hypertensive type. 
We propose a model of retinal angiopathy of 
hypertensive type, which pathogenesis is associated 
with the development of hypertension in rats on the 
background of daily i/p administration of L-NAME in a 
dose 12.5 mg/kg/day for 28 days (SBP 204.8 mmHg, 
DBP 164.2 mmHg in a group with pathology; SBP 
139.2 mmHg, DBP 104.2 mmHg in the intact group, 
p<0.05).  The confirmation of the formation of vascular 
changes in hypertensive type in the retina were results 
of ophthalmoscopy, LDF and ERG. 
The study of retinoprotective action of 
minoxidil, sildenafil compared to DIP on model of 
retinal angiopathy of hypertensive type in experiment 
includes the following groups: 
The first (n = 10) - the group of intact animals, 
the second (n = 10) - the group with the 
modeling of retinal angiopathy (control), 
the third (n = 10) - with the correction of 
pathology by minoxidil, 
the fourth (n = 10) - with the correction of 
pathology by sildenafil, 
the fifth (n = 10) - with the correction of 
pathology by DIP, 
the sixth (n = 10) – with the introduction of 
glibenclamide and modeling of retinal angiopathy, 
the seventh (n = 10) - with the introduction of 
glibenclamide and correction of pathology by 
minoxidil, 
the eighth (n = 10) – with the introduction of 
glibenclamide and correction of pathology by 
sildenafil, 
the ninth (n = 10) - with the introduction of 
glibenclamide and correction of pathology by DIP. 
Results. 
We have developed a model of retinal 
angiopathy of hypertensive type in Wistar rats on the 
background of daily i/p administration of L-NAME 
in a dose 12.5 mg/kg/day for 28 days. 
In accordance with the protocol the anesthesia of 
animals was carried out (chloral hydrate solution i/p 
300 mg/kg) on 29 day of the experiment. Then were 
performed: ophthalmoscopy, assess the level of 
microcirculation in the retina by LDF, retinal 
electrophysiological status by ERG. 
Example of ophthalmoscopy on intact animal is 
shown in fig. 1.  
Example of ophthalmoscopy on animal with 
retinal angiopathy of hypertensive type shown in fig. 2. 
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Figure 1. Example of ophthalmoscopy on intact Wistar rat. Optic disc is circular or oval shape and stands out from the fundus 
in pale - pink. The boundaries of the optic nerve disc are clear. It lies in the plane of the retina. From the middle of the optic 
nerve exit the central vessels of the retina. Blood vessels of the retina don`t have anastomoses. The veins and arteries are 
straightforward, caliber is uniform, not crimped. The general background is pink. 
 
 
 
Figure 2. Example of ophthalmoscopy on Wistar rat with retinal angiopathy of hypertensive type. Optic disc is circular or oval 
shape and stands out from the fundus in pink. The boundaries of the optic nerve disc are clear. Veins are congested, full-
blooded, crimped at the periphery. Arteries are narrowed, slightly crimped. Retina is palely (ischemic). No hemorrhage. 
Symptom Salus-Hun I-III (arrows show). 
  
Thus, the results of fundus research during 
ophthalmoscopy in experimental animals have found 
that the modeling of retinal angiopathy of 
hypertensive type with administration of L-NAME 
for 28 days leads to a pronounced vascular changes in 
the retina and signs of ischemic damage. Integral 
evaluation showed, respectively, 0 and 3 points for 
intact rats and for rats with retinal angiopathy of 
hypertensive type (tab. 2). 
Table 2. 
Integral assessment of fundus changes, detected during ophthalmoscopy (scores 0-5; n = 10). 
Experimental groups Integral assessment in scores 
Intact 0 
With the modeling of retinal angiopathy of hypertensive type 3* 
Note. * - p<0.05 compared with the group of intact animals  
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The microcirculation level in the retina of intact 
animals was 743.6 ± 20.9 p.u. After pathology 
simulation in animal group the microcirculation level on 
29 day of experiment was 431.4 ± 13.8 p.u., which is 
less than in the group of intact animals by 42%. LDF 
data obtained in the control group was significantly 
different from that of the group of intact animals 
(p<0.05) and confirm the formation of ischemia during 
the modeling of retinal angiopathy of hypertensive type. 
Violations in hemodynamics led to changes inherent 
to retinal angiopathy of hypertensive type, which is also 
confirmed by the results of electrophysiological studies 
of retinal conditions. To assess the severity of the 
functional changes in the retina we used the ratio b-wave 
amplitude to the amplitude of a wave of the ERG - the 
coefficient b/a [19].  
In the experimental evaluations of 
electrophysiological condition of rat retina it has been 
found that the ratio b/a in the group of intact animals 
was 2.6 ± 0.07 r.u., in the group with pathology 
simulation this index was significantly different from 
the values in the group of intact animals and was 2,2 ± 
0,09 r.u. (p<0.05), lower than in the group of intact 
animals by 15%. 
The data obtained allow us to conclude that the 
modeling of retinal angiopathy of hypertensive type 
causes a disturbance of electrophysiological state of 
inner retinal layers, which is characterized by 
decrease in the electrophysiological activity of the 
bipolar cells, Muller cells, amacrine and horizontal 
cells, due to violations of the retinal blood flow and 
the ischemia formation. 
Data obtained during ophthalmoscopy, an 
integrated evaluation of the fundus changes, LDF 
and ERG in intact and control groups confirm the 
adequacy of the proposed model of retinal 
angiopathy of hypertensive type on Wistar rats for 
further research of retinoprotective properties of 
pharmacological agents. 
This model is characterized by: 
 severe vascular changes of hypertensive type 
in the retina and attributes of ischemic injury (3 
points, p<0.05 compared with the group of intact 
animals) during ophthalmoscopy and integral 
evaluation of the fundus changes; 
 statistically significant difference between 
values of the microcirculation level in the retina of rats 
in control group from values in the intact group on day 
29 of the experiment after pathology modeling; 
 significant reduction of coefficient b/a of 
electroretinogram after the pathology simulation on 
29 day of the experiment in comparison with the 
value in the group of intact animals. 
Further the study of retinoprotective action of 
minoxidil, sildenafil on the model of retinal angiopathy 
of hypertensive type compared to distant ischemic 
preconditioning and proof implementation of 
pharmacological effect through the participation of the 
ATP-dependent potassium channels were carried out. 
On day 29 of the experiment anesthesia of 
animals was performed (chloral hydrate solution 
i/p 300 mg/kg). Further ophthalmoscopy were 
performed in groups of experimental animals. The 
experiment included 90 Wistar rats. 
 Example of ophthalmoscopy on Wistar rat with 
the correction of retinal angiopathy of hypertensive 
type by minoxidil is shown in fig. 3. 
 
Figure 3. Example of ophthalmoscopy on Wistar rat with the correction of retinal angiopathy of hypertensive type by minoxidil in a 
dose of 0.5 mg/kg on day 29 of the experiment. Optic disc is circular or oval shape and stands out from the fundus in pale - pink.  
The boundaries of the optic nerve disc are clear. It lies in the plane of the retina. Blood vessels of the retina don`t have anastomoses.  
The veins and arteries are straightforward, no crimping. Slightly dilated veins at the periphery. The general background is pink,  
not ischemic. 
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Example of ophthalmoscopy on Wistar rat with 
the correction of retinal angiopathy  
of hypertensive type by sildenafil is shown in fig. 4. 
 
Figure 4. Example of ophthalmoscopy on Wistar rat with the correction of retinal angiopathy of hypertensive type by sildenafil 
in a sode 0.5 mg/kg on day 29 of the experiment. Optic disc is circular or oval in shape and stands out from the fundus in pale - 
pink. The boundaries of the optic nerve disc are clear. It lies in the plane of the retina. There is a slight vasoconstriction, "the 
phenomenon of chiasm", a symptom Salus-Hun I (arrow). Veins are crimped at the periphery. The background is slightly paly. 
 
Example of ophthalmoscopy  
on Wistar rat with the correction  
of retinal angiopathy of hypertensive type by DIP is 
shown in fig. 5. 
 
 
 
Figure 5. Example of ophthalmoscopy on Wistar rat with the correction of retinal angiopathy of hypertensive type by distant 
ischemic preconditioning on the 29 day of the experiment. Optic disc is circular or oval shape and stands out from the fundus 
of the eye in pink. The boundaries of the optic nerve disc are clear. It lies in the plane of the retina. There is a slight 
vasoconstriction, "the phenomenon of chiasm", a symptom Salus-Hun I, II (arrows show). Expansion of veins on both sides of 
the chiasm. Veins are crimped at the periphery. The background is slightly paly. 
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Integral assessment of fundus changes in 
experimental groups with the correction of pathology, 
detected during ophthalmoscopy, is presented in the 
table. 3. 
Table 3. 
Influence of minoxidil, sildenafil and DIP on the complex fundus changes, found during ophthalmoscopy, on model of 
retinal angiopathy of hypertensive type (n = 10). 
Experimental groups Integral assessment in scores 
Intact 0 
With the modeling of retinal angiopathy of hypertensive type (control) 3* 
Control + minoxidil, 0.5 mg/kg 0-1 
Control + sildenafil, 0.5 mg/kg 1 
Control + DIP 2* 
Control + glibenclamide, 5 mg/kg 3* 
Control + minoxidil, 0.5 mg/kg + glibenclamide, 5 mg/kg 2-3* 
Control + sildenafil, 0.5 mg/kg + glibenclamide, 5 mg/kg 3* 
Control + DIP + glibenclamide, 5 mg/kg 3* 
Note. * - p<0.05 compared with the group of intact animals
 
 
Thus, the results of research of fundus during 
ophthalmoscopy and integral evaluation of the fundus 
changes in animal groups with the correction by 
minoxidil, sildenafil, DIP found pronounced 
retinoprotective effect of minoxidil in a dose 0.5 
mg/kg, exceeding sildenafil in a dose 0.5 mg/kg and 
DIP consisting in reducing of ischemic injury to the 
retina and vascular changes of hypertensive type, 
which were observed in the control group. Integral 
evaluation showed, respectively, 0-1, 1 and 2 points 
for the groups of animals with the correction of 
minoxidil, sildenafil and DIP. 
Introduction of glibenclamide in a dose 5 mg/kg 
90 minutes before the administration of L-NAME in 
odd days of the experiment resulted in complete 
elimination of the positive effects of the correction of 
retinal angiopathy of hypertensive type by minoxidil, 
sildenafil, DIP, which confirms the implementation 
of protective effects due to the participation of ATP-
sensitive potassium channels. 
Assessment of the microcirculation level in the 
retina in experimental groups was performed by the 
LDF on 29 day of the experiment after 
ophthalmoscopy. The results are shown in table. 4. 
The microcirculation level in the retina of intact 
rats was 743.6 ± 20.9 p.u. After the modeling of 
pathology in group of animals on day 29 of the 
experiment the level of microcirculation was 431.4 ± 
13.8 p.u., which was significantly different from the 
values in the group of intact animals (p<0.05). In 
group with correction of pathology by minoxidil the 
microcirculation level in the retina was 730.5 ± 15.9 
p.u., which was significantly different from the 
values in the control group (p<0.05), and tends to the 
value in the group of intact animals. Against the 
background of the correction of pathology by 
sildenafil the level of microcirculation in the retina 
was 605.1 ± 19.8 p.u, which was significantly 
different from the value in the control group (p<0.05) 
and the value in the group of intact animals (p<0.05 ). 
Against the background of the correction of retinal 
angiopathy of hypertensive type by DIP the level of 
microcirculation in the retina was 510.8 ± 16.5 p.u., 
which was significantly different from the value in 
the group with pathology (p<0.05) and the value in 
the group of intact rats (p<0.05). 
With the administration of glibenclamide i/g in a 
dose 5 mg/kg the improving of blood flow in the 
retina were not observed in any of the experimental 
groups with the correction of pathology - 
microcirculatory level values were not significantly 
different from the value in the control group. This 
fact confirms the implementation of protective effects 
of minoxidil, sildenafil and DIP through the 
participation of ATP-dependent potassium channels. 
 
Table 4. 
Level of microcirculation in rat retina on day 29 of the experiment  (M ± m; n = 10), p.u. 
Experimental groups Level of microcirculation 
Intact 743,6±20,9у 
With the modeling of retinal angiopathy of hypertensive type (control) 431,4±13,8* 
Control + minoxidil, 0.5 mg/kg 730,5±15,9у 
Control + sildenafil, 0.5 mg/kg 605,1±19,8*у 
Control + DIP 510,8±16,5*у 
Control + glibenclamide, 5 mg/kg 439,4±14,5* 
Control + minoxidil, 0.5 mg/kg + glibenclamide, 5 mg/kg 436,2±12,9* 
Control + sildenafil, 0.5 mg/kg + glibenclamide, 5 mg/kg 441,4±15,8* 
Control + DIP + glibenclamide, 5 mg/kg 430,6±13,2* 
Note. * - p<0.05 compared with the group of intact animals; y - p<0.05 compared with the control group 
 Peresypkina A.A., Gubareva V.O., Levkova E.A., Shabelnikova A.S. Correction of retinal angiopathy of 
hypertensive type by minoxidil, sildenafil in experiment. Research result: pharmacology  
and clinical pharmacology. Vol. 2, №4 (2016): 34-44. 
41 
 
RESEARCH RESULT:  
PHARMACOLOGY AND CLINICAL PHARMACOLOGY 
ERG on evoked potential was performed after 
the measuring of the microcirculation level in the 
retina. The data obtained are presented in table 5.
Table 5. 
The results of evaluation of retinal electrophysiological state  on day 29 of the experiment (M ± m; n = 10) r.u. 
Experimental groups b/a 
Intact 2,6±0,07у 
With the modeling of retinal angiopathy of hypertensive type (control)  2,2±0,09* 
Control + minoxidil, 0.5 mg/kg 2,5±0,09у 
Control + sildenafil, 0.5 mg/kg 2,3±0,08* 
Control + DIP 2,3±0,10* 
Control + glibenclamide, 5 mg/kg 2,2±0,08* 
Control + minoxidil, 0.5 mg/kg + glibenclamide, 5 mg/kg 2,3±0,09* 
Control + sildenafil, 0.5 mg/kg + glibenclamide, 5 mg/kg 2,2±0,05* 
Control + DIP + glibenclamide, 5 mg/kg 2,2±0,09* 
Note. * - p<0.05 compared with the group of intact animals; y - p<0.05 compared with the control group 
 
 
The coefficient b/a in control group was 2.2 ± 
0.09 r.u., which was significantly different from 
the value in the group of intact animals. Increase of 
this indicator in group with the correction by 
minoxidil up to 2.5 ± 0.09 r.u. says about the 
preservation of retinal electrophysiological 
function after disease modeling. In groups of 
animals with the correction by sildenafil and DIP 
ratio b/a was 2.3 ± 0.08 r.u. and 2.3 ± 0.10 r.u. 
accordingly, that significantly differs from the 
group of intact animals and confirms the 
conservation of functional retinal activity in both 
cases. 
Introduction of glibenclamide in animal 
groups with the correction of pathology led to 
decrease of the index b/a on 29 day of the 
experiment to a value, significantly different from 
the value of the group of intact animals, indicating 
on the blockade of the ATP-dependent potassium 
channels and confirms the preconditioning 
properties, in particular, minoxidil in a dose 0.5 
mg/kg on the model of retinal angiopathy of 
hypertensive type. 
Reducing of the ratio b/a in animals with 
simulated pathology caused by inhibition of the 
positive b-wave, which indicates violation of 
electrophysiological function of bipolar and Muller 
cells, as well as the possible contribution of the 
horizontal and amacrine cells. Saving of the 
electrophysiological function of the photoreceptor 
layer is confirmed by the absence of adverse 
changes of  a-wave (fig. 6). 
The observed changes in the functional activity 
of the retina during the ERG in modeling of retinal 
angiopathy of hypertensive type confirm the 
adequacy of the proposed model of pathology. 
Discussion. 
The main factors in the development of retinal 
angiopathy of hypertensive type are disorders of 
common hemodynamics, local changes in the vessel 
walls. From local changes are the most important 
violations of the vascular endothelium [20].  
In this regard, there is a need to find new 
methods of retinoprotection for possible reduction of 
the damaging effect of ischemia, formed in the retinal 
angiopathy of hypertensive type. Segment of drugs 
for the treatment of vascular diseases of the eye as a 
complication of systemic diseases is expedient to 
expand due to the increasing of incidence and lack of 
funds for targeted correction of ischemic lesions of 
the eye vessels [21]. 
Drugs used for correction of retinal ischemic 
damages are nonspecific therapy and do not have the 
desired result, that problem can be solved by 
pharmacological preconditioning, which is able to 
protect the retina from ischemic injury [22]. Versatility 
of preconditioning mechanism gives the background to 
the study of this phenomenon on the retina. 
ATP-dependent potassium channel opening 
during ischemia plays a central role in the mechanism 
of cytoprotective effects of ischemic preconditioning. 
Initially, their activity was detected at sarcolemmal 
membrane, and later at the mitochondrial level. 
Based on the fact that electrophysiological 
studies often have a decisive importance in the early 
and differential diagnosis of retinal disorders [23], to 
study the correction of functional changes in the 
retina, researcher must conduct a comprehensive 
analysis, including ophthalmoscopic, 
electroretinography, microcirculation research. 
Analysis of the dynamics of retinal electrogenesis 
allows to evaluate the nature and topography of 
retinal disorders, as well as to identify the most labile 
hypoxic retinal structure, their reaction to the 
correction by the medications. 
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Figure 6. Electroretinogram of rats: A – ERG of intact animal; B – ERG of animal with retinal angiopathy of hypertensive type 
(inhibition of b-wave is observed) on day 29 of the experiment 
 
The foregoing predetermined the need to 
develop and systematize the methodological 
approaches to the assessment of the functional state 
of the retina and the subsequent optimization of 
correction of retinal angiopathy of hypertensive type. 
The studies conducted in our experiments on Wistar 
rats had developed a set of methodological 
approaches to assess the functional status of the 
retina, including instrumental methods of analysis 
(ophthalmoscopy, LDF, ERG). 
The first step in exploring of the possibility of 
correction of retinal angiopathy of hypertensive type 
using distant and pharmacological preconditioning by 
minoxidil, sildenafil has been the development of 
model of retinal angiopathy of hypertensive type on 
Wistar rats. We evaluated the fundus changes, the 
microcirculation level in the retina and its 
electrophysiological condition. 
Simulation of retinal angiopathy of hypertensive 
type performed by administration of nonselective 
ΝΟ-synthase inhibitor N-nitro-L-arginine methyl 
ester (L-NAME) in a dose 12.5 mg/kg body weight 
of rat for 28 days. 
28 days to Wistar rats corresponds to about 3.5 
years for humans. During this time, the person on a 
background of hypertension has generated retinal 
vascular changes of hypertensive type. Hypertensive 
neuroretinopathy formed over decades, often 
developing in the late period of hypertensive disease 
and usually is a poor prognostic sign. It is 
characterized not only by changes in the blood 
vessels and retinal tissue, and involvement in the 
process of the optic nerve, which becomes swollen, 
a - wave 
B 
b - wave 
a - wave b - wave 
A 
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increased in size, swelling extends to the retina. 
Around the disk and on it hemorrhages are marked. 
Ophthalmoscopic picture is similar to the symptoms 
of stagnant disc, but unlike it marked a dramatic 
violation of color vision, decreased visual function: 
the decline of central vision and the narrowing of the 
field of view. At the end of neuroretinopathy the 
atrophy of the optic nerve may develop. 
Summarizing the above, it should be noted that 
the proposed methodical complex of evaluation of 
functional changes associated with the development 
of retinal angiopathy of hypertensive type, makes 
possible to sufficiently evaluate objectively the 
retinoprotective effects of pharmacological agents. 
The experiment showed that minoxidil in a dose 
0.5 mg/kg prevented the development of ischemic 
damage and retinal vascular changes of hypertensive 
type caused by the introduction of L-NAME for 28 
days, to a greater extent than sildenafil and distant 
ischemic preconditioning. It was revealed that in 
experimental group of animals treated with minoxidil 
in a dose 0.5 mg/kg was a significant difference of all 
measured parameters (the integral evaluation of the 
fundus changes, detected during ophthalmoscopy, the 
level of the microcirculation in the retina, the values 
of the coefficient b/a of electroretinogram) from 
value in the control group, which makes possible to 
talk about the ability of minoxidil in a dose 0.5 mg/kg 
to exert  retinoprotective action on model of retinal 
angiopathy of hypertensive type in experiment. 
The coefficient b/a of ERG in groups with 
correction by sildenafil and DIP statistically 
significantly different from the value in the group of 
intact animals, which makes impossible to speak 
about full retinoprotection, which is observed in the 
group of animals treated with minoxidil. 
In proof of protection of retinal layers due to the 
effect of preconditioning of study drugs served the 
additional administration of glibenclamide in a dose 5 
mg/kg, blocking ATP-dependent potassium channels, 
resulting in the elimination of the observed 
retinoprotective effects and confirms the 
preconditioning effects of minoxidil in a dose 0.5 
mg/kg and sildenafil in a dose 0.5 mg/kg on the 
model of retinal angiopathy of hypertensive type. 
Thus, the prospects become apparent to optimize 
pharmacotherapy of conditions accompanied by 
retinal ischemia, which are closely linked with the 
task of forming the methodology of the study 
antiischemic activity of pharmacologic agents based 
on an adequate assessment of the functional condition 
of the retina by instrumental methods of analysis. 
 
 
Conclusion.  
As a result, we developed a model of retinal 
angiopathy of hypertensive type. An integrated 
assessment of the fundus, the level of 
microcirculation, retinal electrophysiological state 
have been carried out, that allows us to appreciate 
fully the functional condition of the retina in the 
modeling of pathology and its correction. 
This model of pathology allowed to estimate the 
possibility of preconditioning of retina by minoxidil 
in a dose 0.5 mg/kg, by sildenafil in a dose 0.5 mg/kg 
compared to the distant ischemic preconditioning. 
Intragastric administration of minoxidil ni a dose 0.5 
mg/kg 60 minutes before the administration of L-
NAME in odd days of experiment (every 48 hours) 
resulted in prevention of ischemic injury and retinal 
vascular changes of hypertensive type, significant 
increase in the level of microcirculation, preservation 
of electrophysiological retinal activity more than 
sildenafil in a dose 0.5 mg/kg and distant ischemic 
preconditioning.  
Prior administration of glibenclamide in a dose 5 
mg/kg eliminated the positive effects of the study drugs 
and DIP, which confirms the implementation of 
retinoprotection by preconditioning, carried out with the 
participation of ATP-dependent potassium channels. 
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